| European Case Law Identifier: | ECLI:EP:BA:2012:T103408.20120329 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 29 March 2012 | ||||||||
| Case number: | T 1034/08 | ||||||||
| Application number: | 00907228.1 | ||||||||
| IPC class: | A61K 9/107 A61K 9/00 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Microemulsions with adsorbed macromolecules and microparticles | ||||||||
| Applicant name: | Novartis Vaccines and Diagnostics, Inc. | ||||||||
| Opponent name: | GlaxoSmithKline Biologicals SA | ||||||||
| Board: | 3.3.02 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Admissibility of opposition - (yes): opponent clearly identifiable All requests - allowability of amendments - (no): new specific combinations Auxiliary requests I to V - extension of the protection conferred - (yes) |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t081034eu1.html
Date retrieved: 17 May 2021